On the trail of a targeted therapy for blood cancers
Indiana University School of Medicine researchers are focusing on a family of blood proteins that they hope holds a key to decreasing the toxic effects of chemotherapy in children and adults. Their findings may one day help in the development of targeted therapies for leukemia, multiple myeloma and other cancers of the blood.
More: continued here